Nanotechnology and the Pace of Regulation
Does nanotechnology hold the future of drug delivery? From the number of early research studies connecting drug delivery methods with nano-scale science, it would be tough to argue that it doesn’t. FDA recognized this when it formed its Nanotechnology Task Force in 2006 and Nanotechnology Interest Group in 2007. Although no new announcements have been released from the groups since last year, the research and development arena has been busy. Read more »
My conversation with a contract developer on the show floor this morning confirmed what I’d been hearing: drug companies are searching for new routes of administation for their established drugs. Though there’s been an increase in candidates in Phase I and Phase II studies, fewer candidates are making it to Phase III and commercialization than in the past. 